Purpose: To improve the understanding of hepatic carcinosarcoma (HCS) by analyzing radiological imaging data and clinicopathological features.
Materials And Methods: A retrospective analysis was performed on four patients with HCS confirmed immunohistochemically. The analysis included three males and one female, aged 29 to 64 years. Four patients underwent computed tomography (CT) scans, and one underwent magnetic resonance imaging (MRI) scans simultaneously.
Results: Three patients had a history of hepatitis B, cirrhosis or fibrosis, and two patients had schistosomiasis. Two cases tested positive for elevated serum carbohydrate antigen (CA) 19-9. The maximum diameters of the lesions ranged from 7.8 to 9.0cm. Pathologically, the carcinomatous and sarcomatous elements in two patients could not be classified, one of the patients had cholangiocellular carcinoma (CCC) and undifferentiated sarcoma, the other had hepatocellular carcinoma (HCC) and undifferentiated pleomorphic sarcoma (UPS). All tumors showed heterogeneous density/intensity, accompanied by vast cystic changes and necrosis, with two cases having cystic septations. Capsule formation was not identified. The margins of the radiological images showed irregular ring enhancement. One case presented continuous progressive enhancement, one case with "fast in fast washout" and two cases with "fast in late washout". Lymphonodus metastasis, satellite nodules, vascular embolism, and organ invasion (hepatic flexure of the colon) were identified.
Conclusion: HCS is a rare, high-grade malignancy with poor prognosis. The preoperative diagnosis is expected to improve by carefully analyzing the imaging features of the patients in combination with their clinical characteristics. Radical resection and postoperative chemoradiotherapy can improve the survival rate of patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568615 | PMC |
http://dx.doi.org/10.2147/JHC.S272768 | DOI Listing |
Asian J Surg
August 2024
Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, Shandong Province, China. Electronic address:
Asian J Surg
July 2024
Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang, 050051, China. Electronic address:
Asian J Surg
September 2024
Interventional Radiology Department, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004, China. Electronic address:
Medicine (Baltimore)
May 2024
Department of Gastrointestinal Surgery, Weihai Central Hospital, Qingdao University, Weihai, China.
Medicina (B Aires)
April 2024
Instituto de Oncología, Hospital Alemán de Buenos Aires, Argentina.
Primary hepatic sarcomatoid carcinoma is a very aggressive tumor, representing 0.4-0.7% of all primary hepatic neoplasms.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!